Literature DB >> 8406831

Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

P A Trinel1, M Borg-von-Zepelin, G Lepage, T Jouault, D Mackenzie, D Poulain.   

Abstract

Western blot (immunoblot) analysis of Candida albicans germ tube extracts has demonstrated the probable presence of beta-1,2-linked oligomannosides acting as epitopes distributed over a 14- to 18-kDa antigen unreactive to concanavalin A. These conclusions about the existence of these non-mannan-associated oligomannoside species were reinforced in the present study by the demonstration of reactivity of factor serum 5 (Iatron Laboratories) with the same antigen. A monoclonal antibody which reacted in an enzyme immunoassay with beta-1,2-linked oligomannosides converted into neoglycolipids and in Western blotting with the 14- to 18-kDa antigen from yeast and germ tubes, through metaperiodate-sensitive epitopes, was used for further characterization of the molecule. Reducing agents and strong protease digestion, which have deleterious effects on C. albicans proteins and mannoproteins, affected neither the antigenicity nor the relative molecular weight of the molecule. Western blots performed after migration of protease-treated extracts in polyacrylamide gels without sodium dodecyl sulfate (SDS) showed that the 14- to 18-kDa antigen could be negatively charged, whereas metabolic radiolabeling demonstrated that these charges could originate, at least in part, from the presence of phosphorus within the molecule. Chloroform-methanol-water extraction of protease-resistant material led to purification of the 14- to 18-kDa antigen, as determined by SDS-polyacrylamide gel electrophoresis and Western blotting. Metabolic radiolabeling with mannose confirmed the presence of these sugar residues within the purified 14- to 18-kDa antigen (despite its nonreactivity to concanavalin A), whereas radiolabeling with palmitic acid demonstrated its lipopolysaccharidic nature. Together, these results led to the conclusion that the 14- to 18-kDa antigen is a phospholipomannan.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406831      PMCID: PMC281172          DOI: 10.1128/iai.61.10.4398-4405.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli.

Authors:  S W Hunter; H Gaylord; P J Brennan
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

2.  Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation.

Authors:  M P Woodward; W W Young; R A Bloodgood
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303

3.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

4.  Enzymatic release of germ tube-specific antigens from cell walls of Candida albicans.

Authors:  P M Sundstrom; G E Kenny
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238.

Authors:  M Borg-von Zepelin; V Grüness
Journal:  J Med Vet Mycol       Date:  1993

6.  Identification of Candida albicans cell wall antigens lost during subculture in synthetic media.

Authors:  F L Hernando; J J Estevez; M Cebrian; D Poulain; J Ponton
Journal:  J Med Vet Mycol       Date:  1993

7.  Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T.

Authors:  N Shibata; H Kobayashi; M Tojo; S Suzuki
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

8.  Immunoblotting analysis of sera from patients with candidal vaginitis and healthy females.

Authors:  A Ishiguro; M Homma; T Sukai; K Higashide; S Torii; K Tanaka
Journal:  J Med Vet Mycol       Date:  1992

9.  Probable presence of beta(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14- to 18-kilodalton antigen.

Authors:  D Poulain; C Faille; C Delaunoy; P M Jacquinot; P A Trinel; D Camus
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  The Leishmania receptor for macrophages is a lipid-containing glycoconjugate.

Authors:  E Handman; J W Goding
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  23 in total

Review 1.  Candida albicans phospholipomannan: a sweet spot for controlling host response/inflammation.

Authors:  Chantal Fradin; Emerson Soares Bernardes; Thierry Jouault
Journal:  Semin Immunopathol       Date:  2014-11-14       Impact factor: 9.623

2.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 3.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.

Authors:  T Jouault; C Delaunoy; B Sendid; F Ajana; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 5.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Common and form-specific cell wall antigens of Candida albicans as released by chemical and enzymatic treatments.

Authors:  J L López-Ribot; M Casanova; M L Gil; J P Martinez
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

8.  New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis.

Authors:  B Sendid; M Tabouret; J L Poirot; D Mathieu; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis.

Authors:  F De Bernardis; A Molinari; M Boccanera; A Stringaro; R Robert; J M Senet; G Arancia; A Cassone
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains.

Authors:  H Kobayashi; K Matsuda; T Ikeda; M Suzuki; S Takahashi; A Suzuki; N Shibata; S Suzuki
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.